Opus Genetics, Inc. Share Price
Opus Genetics, Inc. (IRD) had Share Price of $9.60 per share as of 2019-01-25, per its 10-K filed 2020-02-21.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2020-02-21
- 2019-01-25: Share Price $9.60.
- 2018-10-19: Share Price $15.60; Share Price as first filed $1.30.
- 2017-10-17: Share Price $2.45.
- 2017-06-12: Share Price $3.30.
| Period end | Share Price | Share Price as first filed |
|---|---|---|
| 2019-01-25 | $9.60 10-K · filed 2020-02-21 | |
| 2018-10-19 | $15.60 10-K · filed 2020-02-21 | $1.30 10-K · filed 2019-03-07 |
| 2017-10-17 | $2.45 10-K · filed 2019-03-07 | |
| 2017-06-12 | $3.30 10-K · filed 2019-03-07 | |
| 2016-09-19 | $2.50 10-K · filed 2018-03-09 | $0.25 10-Q · filed 2016-11-04 |
| 2016-03-02 | $3.20 10-K · filed 2018-03-09 | $0.32 10-Q · filed 2016-05-06 |
| 2015-12-31 | $7.41 10-K · filed 2018-03-09 | $0.74 10-K · filed 2017-02-24 |
| 2015-11-12 | $4.20 10-K · filed 2018-03-09 | $0.42 10-K · filed 2016-03-14 |
| 2015-09-30 | $0.74 10-Q · filed 2015-11-02 | |
| 2015-07-01 | $0.61 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $0.74 10-Q · filed 2015-08-07 | |
| 2015-03-16 | $0.74 10-K · filed 2016-03-14 | |
| 2015-02-10 | $0.75 10-Q · filed 2015-11-02 | |
| 2014-08-01 | $0.73 10-K · filed 2015-03-16 | |
| 2014-02-10 | $1.12 10-K · filed 2015-03-16 | |
| 2014-01-21 | $1.05 10-K · filed 2017-02-24 | |
| 2013-10-16 | $0.52 10-K · filed 2016-03-14 | |
| 2013-10-10 | $0.53 10-K · filed 2015-03-16 | |
| 2013-08-01 | $0.53 10-K · filed 2015-03-16 | |
| 2013-07-26 | $0.50 10-K · filed 2016-03-14 | |
| 2013-06-10 | $0.50 10-K · filed 2015-03-16 | |
| 2013-05-10 | $0.31 10-K · filed 2015-03-16 | |
| 2012-12-04 | $0.33 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |